Company Profile

Optobionics Corporation
Profile last edited on: 5/2/08      CAGE:       UEI:

Business Identifier: Opto-electronic implants to treat retinal diseases, blindness: Artificial Silicon Retina Devices
Year Founded
1995
First Award
1997
Latest Award
1997
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

850 East Diehl Road Suite 120
Naperville, IL 60563
   (630) 245-0600
   info@optobionics.com
   www.optobionics.com
Location: Single
Congr. District: 06
County: DuPage

Public Profile

Optobionics' Artificial Silicon Retina (ASR) may be used as a stand-alone implant that is placed behind the retina (subretinal approach) to directly stimulate the remaining viable cells of the retina. An array of microphotodiodes is fabricated on the chip so that the chip itself converts light energy to electrical signals. These are designed to directly stimulate the remaining overlying cells of the retina. We understand other approaches utilize implants, positioned on the surface of the retina (epiretinal approach), to try to stimulate the nerve-fiber layer or ganglion cells. We also understand that these other devices are designed to function in conjunction with computers, video cameras, lasers, and/or radio frequency transmitters. Thus Optobionics' subretinal approach differs from the epiretinal approach in that: (1) the design of our chip is relatively simple and may be able to function solely with the power provided by light entering into the eye—presently our chip does not require connecting wires, batteries, or other ancillary devices—and (2) the placement of our chip is in contact with earlier processing cells of the retina, so that some level of normal retinal processing of images may be possible. This will hopefully allow the chip to generate relatively high quality imag

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1997 1 NIH $100,000
Project Title: Subretinal Silicon Microphotodiode Retinal Prosthesis

Key People / Management

  John Parrish -- President

  Alan Y Chow

Company News

There are no news available.